Acquiring Company
Faeth Therapeutics
Acquired Company
Faeth
AustinBiotechnologyHealth CareMedicalTherapeuticsresearchDescription
Sensei Biotherapeutics has acquired Faeth as part of its strategy to enhance its cancer treatment capabilities. This acquisition contributed to a net loss of $170.2M, attributed to acquisition costs. The company is making progress with its lead program, PIKTOR, which targets certain cancer pathways. This move aims to strengthen Sensei's position in the oncology market.
Who to call at Faeth Therapeutics, and when
When Faeth Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Faeth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Faeth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Faeth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Faeth Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Faeth?
Faeth was acquired by Faeth Therapeutics, based in Austin. The deal was reported on May 16, 2026. Rather the company is aiming to interrogate how nutrition can become a “fifth pillar” of cancer care through scientific study. The company also has another trial aimed at metastatic colorectal cancer. Faeth Therapeutics is publicly traded (FTH) and operates in Biotechnology.
When did Faeth Therapeutics acquire Faeth?
Faeth Therapeutics's acquisition of Faeth was reported on May 16, 2026. Sensei Biotherapeutics has acquired Faeth as part of its strategy to enhance its cancer treatment capabilities. This acquisition contributed to a net loss of $170.2M, attributed to acquisition costs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Faeth do?
Faeth is a biotech company engaged in developing therapies for cancer through innovative approaches. The specifics of its operations and research focus are less publicly detailed. The company's acquisition enhances Sensei's portfolio in cancer treatment. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.